THE 9th Sugiyama Laboratory Open Symposium

 Role of DMPK scientists in bringing precision medicine into real-world

Date:Oct 20 13:50-17:50, 2017

Place: RIKEN Yokohama Main Building Hall 

Language:English

Registration Fee: Symposium Free, banquet 3,000yen

 

Registration ; mail to  yslab.secretary [at] ml.riken.jp with below information.

 

 name/affiliation/mail address/banquet(attend or not)

 

 

 

 

 

This Symposium is a part of the RIKEN Symposium Series.

Program

THE 10th RIKEN SYMPOSIUM.pdf
Adobe Acrobat ドキュメント 69.8 KB

13:50-14:00

 

Opening remarks

Yuichi Sugiyama (Sugiyama Laboratory, RIKEN Innovation Center) 

14:00-14:30

 

 

Systems-based understandings of drug toxicities

Masashi Honma (The University of Tokyo Hospital)

14:30-15:00

  

Current Approaches for Evaluating OATP Family Transporters in Drug Discovery
Saki Izumi (Eisai Co., Ltd.)

 

15:00-15:30

 

 

Complex DDI of telaprevir and maraviroc
Emi Kimoto (Pfizer Inc.)

15:30-15:50

Coffee break

15:50-16:20 

 

 

   

Physiologically based pharmacokinetic (PBPK) modeling approach of cerivastatin to quantitatively describe drug-drug interactions associated with hepatic uptake transporter and metabolic enzymes
Yoshiaki Yao (Astellas Pharma Inc.)

16:20-16:50

 

 

 

Kinetic consideration of OATP contribution to drug disposition based on     extended clearance concept: Insight to genetic and ethnic variability and drug-drug interaction
Yoshiko Tomita (Sumitomo Dainippon Pharma Co., Ltd.)

16:50-17:20

 

 

     

Bilirubin and its conjugates levels in the blood circulation can be a bio-marker for drug-drug interaction?: Various drug transporters/drug-metabolism enzymes are involved in bilirubin homeostasis
Seiji Miyauchi (Toho university)

17:20-17:50        

General Discussion

Yuichi Sugiyama (Sugiyama Laboratory, RIKEN Innovation Center)

18:00-19:45

Banquet (Cafeteria at Yokohama RIKEN)

 

Contact to:Sugiyama's Laboratory
Email: yslab.secretary [at] ml.riken.jp
HP: http://www.sugiyamalab.com/
Tel: 045‐503‐9210